Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

Terumo announces global commercial launch of K-Pack Embrace™ Active Safety Needle (opens in a new tab)

news-medical.net · 2026-10-06

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 14 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedTerumo Corporation announced the global commercial launch of its K-Pack Embrace active safety needle.View evidenceHide evidence

As statedglobal commercial launch

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe needle is packaged in a rigid cap and case container designed to facilitate downstream co-packing processes and protect the needle through the product life cycle until point of use.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedTerumo says co-packing a pre-selected injection needle with a drug product and syringe can significantly reduce risks to the patient, add convenience for healthcare professionals, and maintain value for drug companies.View evidenceHide evidence

As statedsignificantly reduce

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedThe K-Pack Embrace is intended for subcutaneous, intramuscular, and intravenous applications and includes Terumo's T-Sharp technology with integrated needle shield safety features.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedTerumo says the active safety needle reduces the risk of needlestick injuries with an integrated hinged needle shield that can be activated with one hand and provides audible, visual, and tactile confirmation of engagement.View evidenceHide evidence

As statedreduces the risk

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Crossref, Europe PMC · 15 candidate papers

And 10 more candidates considered.